CN105497338A - Fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution - Google Patents
Fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution Download PDFInfo
- Publication number
- CN105497338A CN105497338A CN201410499383.1A CN201410499383A CN105497338A CN 105497338 A CN105497338 A CN 105497338A CN 201410499383 A CN201410499383 A CN 201410499383A CN 105497338 A CN105497338 A CN 105497338A
- Authority
- CN
- China
- Prior art keywords
- kidney
- oral solution
- hypolipidemic
- spleen invigorating
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000952 spleen Anatomy 0.000 title claims abstract description 25
- 210000003734 kidney Anatomy 0.000 title claims abstract description 24
- 229940100688 oral solution Drugs 0.000 title abstract 6
- 241001289529 Fallopia multiflora Species 0.000 title abstract 5
- 235000018167 Reynoutria japonica Nutrition 0.000 title abstract 5
- 230000000055 hyoplipidemic effect Effects 0.000 title abstract 5
- 241001648835 Polygonum cuspidatum Species 0.000 title 1
- 239000008280 blood Substances 0.000 claims abstract description 38
- 210000004369 blood Anatomy 0.000 claims abstract description 38
- 239000004615 ingredient Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 18
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000012669 liquid formulation Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 230000001954 sterilising effect Effects 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 6
- 238000000605 extraction Methods 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 2
- 206010008479 Chest Pain Diseases 0.000 abstract description 2
- 208000006011 Stroke Diseases 0.000 abstract description 2
- 210000003414 extremity Anatomy 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 240000001341 Reynoutria japonica Species 0.000 abstract 4
- 235000013291 Alisma plantago aquatica Nutrition 0.000 abstract 2
- 240000004615 Alisma plantago-aquatica Species 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 2
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 2
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 2
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 2
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 2
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 2
- 241000830535 Ligustrum lucidum Species 0.000 abstract 2
- 244000241872 Lycium chinense Species 0.000 abstract 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract 2
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 2
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 235000006533 astragalus Nutrition 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 210000004233 talus Anatomy 0.000 abstract 2
- 206010061876 Obstruction Diseases 0.000 abstract 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 238000004821 distillation Methods 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000005577 familial hyperlipidemia Diseases 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 239000000341 volatile oil Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000522254 Cassia Species 0.000 description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000009395 genetic defect Effects 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- -1 through selecting Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution. The oral solution adopts traditional Chinese medicines fallopia multiflora and polygonum cuspidatum rhizome as the raw materials, and is supplemented by Chinese wolfberry, glossy privet fruit, astragalus, peach kernel, Salvia miltiorrhiza, Radix Paeoniae Rubra, Alisma plantago-aquatica and hawthorn, and by means of selection, extraction, clear paste making and sterilization processes, the kidney tonifying and spleen invigorating hypolipidemic oral solution can be obtained. The fallopia multiflora adopted by the invention has hypolipidemic and antiatherosclerotic Chinese medicinal ingredients, the polygonum cuspidatum rhizome has blood activating and collateral dredging Chinese medicinal components, the added Chinese wolfberry and glossy privet fruit both have liver and kidney nourishing Chinese medicinal components, the astragalus and hawthorn have spleen and stomach strengthening Chinese medicinal components, and together with peach kernel, Salvia miltiorrhiza, Radix Paeoniae Rubra, Alisma plantago-aquatica, the materials are made into the fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution. The oral solution has a reasonable formula and the efficacy of tonifying kidney and invigorating spleen, activating blood and dredging collaterals, etc., is mainly used for treatment of hyperlipoidemia, the symptoms chest obstruction, chest pain, cardiac pain, stroke, dizziness, chest stuffiness and gastric fullness, heavy limbs, white and greasy tongue fur and slippery pulse, and has significant curative effect.
Description
Technical field
The present invention relates to the field of Chinese medicines, espespecially a kind of Radix Polygoni Multiflori Rhizoma Polygoni Cuspidati kidney and spleen invigorating oral administration liquor for reducing blood fat.
Background technology
Hyperlipemia refers to that blood lipid level is too high, directly can cause the disease of some serious harm healths.Hyperlipemia is with simple hypercholesterolemia or simple hypertriglyceridemia or both double metabolism disorder of blood lipid diseases of seeing.With regard to the cause of disease, have plenty of caused by multiple genetic defect and environmental factors interact.Have plenty of that, excessive eating too high by diet satisfied fatty acid, smoking, quantity of motion are few, fat, some drugs etc. causes.What have is then be secondary to other diseases.So hyperlipemia is not a kind of specific disease, but one group of disease.Because blood fat is all exist with protein bound form in blood, so there is again people that hyperlipemia is called hyperlipoproteinemia.The morbidity close relation of hyperlipemia and atherosclerosis, cardiovascular and cerebrovascular disease, diabetes, fatty liver, nephropathy etc. is one of Major Risk Factors forming coronary heart disease.Systemic atherosclerosis is accelerated in the direct infringement of hyperlipemia, because the vitals of whole body all will rely on tremulous pulse blood supply, oxygen supply, once tremulous pulse is blocked by atheromatous plaque, will cause serious consequence.Hyperlipemia also can cause liver injury.When blood fat increase to over organism metabolism need time, fat flushing is piled up to get up to form fatty liver in liver.
Summary of the invention
A kind of Radix Polygoni Multiflori Rhizoma Polygoni Cuspidati of the present invention kidney and spleen invigorating oral administration liquor for reducing blood fat, adopt that Radix Polygoni Multiflori and Rhizoma Polygoni Cuspidati are aided with Fructus Lycii, Fructus Ligustri Lucidi, the Radix Astragali, Semen Persicae, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Rhizoma Alismatis, Fructus Crataegi Chinese medicine are raw material, through selecting, extract, clear paste, sterilization process prepare Radix Polygoni Multiflori Rhizoma Polygoni Cuspidati kidney and spleen invigorating oral administration liquor for reducing blood fat, can realize the object of fast repairing kidney and strengthening spleen blood fat reducing.
To achieve these goals, the technology of the present invention solution is: a kind of major ingredient component of Radix Polygoni Multiflori Rhizoma Polygoni Cuspidati kidney and spleen invigorating oral administration liquor for reducing blood fat: Radix Polygoni Multiflori 18% ~ 20%, Rhizoma Polygoni Cuspidati 5% ~ 7%, Fructus Lycii 8% ~ 10%, Fructus Ligustri Lucidi 8% ~ 10%, the Radix Astragali 10% ~ 12%, Semen Persicae 5% ~ 7%, Radix Salviae Miltiorrhizae 12% ~ 14%, Radix Paeoniae Rubra 6% ~ 8%, Rhizoma Alismatis 6% ~ 8%, Fructus Crataegi 12% ~ 14%.
Step of preparation process is as follows:
(1) select extraction: Fructus Lycii, Fructus Crataegi, Semen Persicae are picked removal impurity respectively, water vapour distillation volatile oil, the another device of the aqueous solution after distillation is collected;
(2) clear paste: getting that above-mentioned medicinal residues and all the other Fructus Ligustri Lucidi, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Rhizoma Alismatis raw material decoct with water is 1-3 time, each 1-2 hour, collecting decoction, filter, filtrate is condensed into the clear paste that relative density is 1.10-1.20, soak, filtrate reconcentration becomes relative density to be the clear paste of 1.10-1.20;
(3) sterilizing: add the aqueous solution after volatile oil and distillation, fill, sterilizing, 10ml/ props up, and obtains kidney and spleen invigorating oral administration liquor for reducing blood fat.
Major ingredient component of the present invention effect and effect:
Radix Polygoni Multiflori: there is blood fat reducing and arteriosclerosis, nourishing the blood and yin, loosening bowel to relieve constipation, preventing the attack (or recurrence) of malaria, dispel the wind, detoxify; Effect of the soreness of the waist and knees of main blood deficiency Light-headedness, cardiopalmus, insomnia, the hepatic and renal YIN deficiency, early whitening of beard and hair, tinnitus, seminal emission, dryness of the intestine constipation, chronic malaria body void, rubella pruritus, carbuncle sore, scrofula, hemorrhoid;
Rhizoma Polygoni Cuspidati: have and dispel the wind, dampness removing, removing blood stasis with potent drugs, to stimulate the menstrual flow; Dispelling the wind and dampness pathogens bones and muscles pain, jaundice due to damp-heat, stranguria with turbid discharge leukorrhagia, women's amenorrhea, lochiostasis, lump in the abdomen, anal fistula hematochezia, injury from falling down, scald, malignant boil tinea disease, arrhythmia and anti-cardiac muscle is lost blood, effect of blood circulation promoting and blood stasis dispelling;
Fructus Lycii: there is nourishing the liver and kidney, replenishing vital essence to improve eyesight.For asthenia damage of essence, soreness of waist and knee joint, vertigo and tinnitus, interior-heat is quenched one's thirst, blood deficiency and yellow complexion, effect that blurred vision is not clear;
Fructus Ligustri Lucidi: there is nourishing the liver and kidney, improving eyesight black hair; Be used for the treatment of effect of vertigo and tinnitus, soreness of the waist and knees, early whitening of beard and hair and poor vision;
The Radix Astragali: there is enhancing human body immunity function, protect the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely; Also has effect of air making-up and spleen enlivening;
Semen Persicae: there is blood stasis removing and clots absorbing, moisturize laxation; Control effect of amenorrhea, lump in the abdomen, calentura blood-retention, migratory arthralgia, malaria, traumatic injury, swelling and pain due to blood stasis, the dry constipation of blood;
Radix Salviae Miltiorrhizae: have and have stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, the effect of the relieving restlessness that clears away heart-fire; Swell and ache for menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection, dysphoria and insomnia, hepatosplenomegaly, the effect such as angina pectoris;
Radix Paeoniae Rubra: there is clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling; Main maculae caused by violent heat pathogen, hematemesis and epistaxis, discharging fresh blood stool, conjunctival congestion and swelling pain, carbuncle skin infection, amenorrhea, dysmenorrhea, metrorrhagia and leukorrhagia stranguria with turbid discharge, the stagnant hypochondriac pain of the stasis of blood, hernia abdominal mass gather, injury from falling down; For effect of maculae caused by violent heat pathogen, hematemesis and epistaxis, conjunctival congestion and swelling pain, hypochondriac pain due to stagnation of liverQI, amenorrhea dysmenorrhea, lump in the abdomen stomachache, injury from falling down, carbuncle skin infection symptom;
Rhizoma Alismatis: there is oedema due to nephritis, pyelonephritis, enteritis are had loose bowels, effect of dysuria symptom;
Fructus Crataegi: have the effects such as blood fat reducing, blood pressure, heart tonifying, arrhythmia, Fructus Crataegi is also the good medicine of spleen benefiting and stimulating the appetite, relieving dyspepsia, phlegm reduction of blood circulation promoting; The disease such as, hernia, blood stasis full to chest and diaphragm spleen, amenorrhea has good curative effect; Flavone compound vitexin in Fructus Crataegi, be the medicine that a kind of antitumaous effect is stronger, Fructus Crataegi extract all has certain inhibitory action to cancerous cell tumor growth, propagation and infiltration metastasis.
Usage and dosage of the present invention: every day 1 10ml, take medicine 6, symptom is clearly better, then takes 15, and cholesterol, triacylglycerol obviously reduce, blood fat stablize; Take 1 month again, consolidate curative effect.
Beneficial effect: the present invention adopts Radix Polygoni Multiflori to have blood fat reducing and arteriosclerosis Chinese medicine ingredients; Rhizoma Polygoni Cuspidati has promoting blood circulation to remove obstruction in the collateral Chinese medicine ingredients; Add Fructus Lycii and Fructus Ligustri Lucidi all has nourishing the liver and kidney Chinese medicine ingredients; The Radix Astragali and Fructus Crataegi have strengthening the spleen and stomach Chinese medicine ingredients; And Semen Persicae, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Rhizoma Alismatis Chinese crude drug make Radix Polygoni Multiflori Rhizoma Polygoni Cuspidati kidney and spleen invigorating oral administration liquor for reducing blood fat, formula is reasonable, has the effect such as kidney and spleen invigorating, promoting blood circulation to remove obstruction in the collateral; Cure mainly hyperlipemia; Disease sees the thoracic obstruction, chest pain, pained, apoplexy, dizzy, breast gastral cavity painful abdominal mass is vexed, limbs are heavy, white and greasy fur, rolling pulse; Evident in efficacy.
Detailed description of the invention
Be described principle of the present invention and feature below in conjunction with embodiment, example, only for explaining the present invention, is not intended to limit scope of the present invention.
Embodiment 1
Major ingredient component: Radix Polygoni Multiflori 18%, Rhizoma Polygoni Cuspidati 5%, Fructus Lycii 9%, Fructus Ligustri Lucidi 8%, the Radix Astragali 11%, Semen Persicae 6%, Radix Salviae Miltiorrhizae 14%, Radix Paeoniae Rubra 8%, Rhizoma Alismatis 7%, Fructus Crataegi 14%.
Step of preparation process is as follows:
(1) select extraction: Fructus Lycii, Fructus Mori are picked removal impurity respectively, water vapour distillation volatile oil, the another device of the aqueous solution after distillation is collected;
(2) clear paste: getting that above-mentioned medicinal residues and all the other Semen Cassiaes, Semen Cuscutae, Fructus Ligustri Lucidi, Fructus Rosae Laevigatae, Semen Astragali Complanati raw material decoct with water is 1 time, each 1 hour, collecting decoction, filter, filtrate is condensed into the clear paste that relative density is 1.10, soaks, filtrate reconcentration become relative density be 1.10 clear paste;
(3) sterilizing: add the aqueous solution after volatile oil and distillation, fill, sterilizing, 10ml/ props up, and obtains kidney and spleen invigorating oral administration liquor for reducing blood fat.
Embodiment 2
Major ingredient component: Radix Polygoni Multiflori 19%, Rhizoma Polygoni Cuspidati 6%, Fructus Lycii 10%, Fructus Ligustri Lucidi 10%, the Radix Astragali 12%, Semen Persicae 5%, Radix Salviae Miltiorrhizae 12%, Radix Paeoniae Rubra 7%, Rhizoma Alismatis 6%, Fructus Crataegi 13%.
Step of preparation process is as follows:
(1) select extraction: Fructus Lycii, Fructus Mori are picked removal impurity respectively, water vapour distillation volatile oil, the another device of the aqueous solution after distillation is collected;
(2) clear paste: getting that above-mentioned medicinal residues and all the other Semen Cassiaes, Semen Cuscutae, Fructus Ligustri Lucidi, Fructus Rosae Laevigatae, Semen Astragali Complanati raw material decoct with water is 2 times, each 1.5 hours, collecting decoction, filter, filtrate is condensed into the clear paste that relative density is 1.15, soaks, filtrate reconcentration become relative density be 1.15 clear paste;
(3) sterilizing: add the aqueous solution after volatile oil and distillation, fill, sterilizing, 10ml/ props up, and obtains kidney and spleen invigorating oral administration liquor for reducing blood fat.
Embodiment 3
Major ingredient component: Radix Polygoni Multiflori 20%, Rhizoma Polygoni Cuspidati 7%, Fructus Lycii 8%, Fructus Ligustri Lucidi 9%, the Radix Astragali 10%, Semen Persicae 7%, Radix Salviae Miltiorrhizae 14%, Radix Paeoniae Rubra 6%, Rhizoma Alismatis 7%, Fructus Crataegi 12%.
Step of preparation process is as follows:
(1) select extraction: Fructus Lycii, Fructus Mori are picked removal impurity respectively, water vapour distillation volatile oil, the another device of the aqueous solution after distillation is collected;
(2) clear paste: get above-mentioned medicinal residues and all the other Semen Cassiaes, Semen Cuscutae, Fructus Ligustri Lucidi, Fructus Rosae Laevigatae, Semen Astragali Complanati raw material decoct with water 3 times, each 2 hours, collecting decoction, filter, filtrate is condensed into the clear paste that relative density is 1.20, soaks, filtrate reconcentration become relative density be 1.20 clear paste;
(3) sterilizing: add the aqueous solution after volatile oil and distillation, fill, sterilizing, 10ml/ props up, and obtains kidney and spleen invigorating oral administration liquor for reducing blood fat.
The above; embodiment is only be described the preferred embodiment of the present invention; not scope of the present invention is limited; under the prerequisite of spirit not departing from the technology of the present invention; the various distortion that this area engineers and technicians make technical scheme of the present invention and improvement, all should fall in protection domain that claims of the present invention determine.
Claims (2)
1. a Radix Polygoni Multiflori Rhizoma Polygoni Cuspidati kidney and spleen invigorating oral administration liquor for reducing blood fat, is characterized in that: the major ingredient component of described Radix Polygoni Multiflori Rhizoma Polygoni Cuspidati kidney and spleen invigorating oral administration liquor for reducing blood fat: Radix Polygoni Multiflori 18% ~ 20%, Rhizoma Polygoni Cuspidati 5% ~ 7%, Fructus Lycii 8% ~ 10%, Fructus Ligustri Lucidi 8% ~ 10%, the Radix Astragali 10% ~ 12%, Semen Persicae 5% ~ 7%, Radix Salviae Miltiorrhizae 12% ~ 14%, Radix Paeoniae Rubra 6% ~ 8%, Rhizoma Alismatis 6% ~ 8%, Fructus Crataegi 12% ~ 14%.
2. a kind of Radix Polygoni Multiflori Rhizoma Polygoni Cuspidati kidney and spleen invigorating oral administration liquor for reducing blood fat according to claim 1, is characterized in that: get above-mentioned raw materials and add customary adjuvant, make oral liquid formulations, also can decoction processed, granule processed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410499383.1A CN105497338A (en) | 2014-09-26 | 2014-09-26 | Fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410499383.1A CN105497338A (en) | 2014-09-26 | 2014-09-26 | Fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105497338A true CN105497338A (en) | 2016-04-20 |
Family
ID=55705898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410499383.1A Pending CN105497338A (en) | 2014-09-26 | 2014-09-26 | Fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105497338A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108157563A (en) * | 2018-03-12 | 2018-06-15 | 童国柱 | A kind of kidney and spleen invigorating mountain cornel tea |
| CN111647489A (en) * | 2020-07-01 | 2020-09-11 | 抚州市临川区米谷酒坊 | Brewing process of medicinal liquor capable of improving human immunity |
-
2014
- 2014-09-26 CN CN201410499383.1A patent/CN105497338A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108157563A (en) * | 2018-03-12 | 2018-06-15 | 童国柱 | A kind of kidney and spleen invigorating mountain cornel tea |
| CN111647489A (en) * | 2020-07-01 | 2020-09-11 | 抚州市临川区米谷酒坊 | Brewing process of medicinal liquor capable of improving human immunity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104758852A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN105168832A (en) | Medicine for treating liver qi stagnation type mammary gland proliferation | |
| CN105497338A (en) | Fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution | |
| CN106729214A (en) | Medicine and preparation method thereof for treating gout | |
| CN102793892B (en) | Traditional Chinese medicine for treatment of gout | |
| CN106109840A (en) | Radix Rehmanniae Pilulae for Improving Eyesight and preparation method thereof | |
| CN104623330A (en) | Chinese medicinal composition for treating hyperlipidemia | |
| CN105435131A (en) | Traditional Chinese medicine composition for treating chronic heart failure and preparation method thereof | |
| CN103405554B (en) | A kind of medicine for the preoperative bowel relieving of abdominal operation | |
| CN102526449B (en) | Drug combination for treating coronary heart diseases caused by myocardial ischemia | |
| CN102526601B (en) | Chinese medicine for treating oligospermatism | |
| CN102349986A (en) | Traditional Chinese medicine for treating climacteric syndrome | |
| CN102406753B (en) | Chinese medicinal composition for treating Bi syndrome | |
| CN105688075A (en) | Novel oral preparation for treating stomachache and preparation method thereof | |
| CN106266474A (en) | For treating the medicine of coronary heart disease | |
| CN104840765A (en) | Drug for treating senile constipation | |
| CN104587275A (en) | Traditional Chinese medicinal composition for treating fire excess from yin deficiency | |
| CN104189656A (en) | Traditional Chinese medicine capsule for treating hyperlipidemia | |
| CN105327024A (en) | Traditional Chinese medicine preparation for treating rheumatoid arthritis | |
| CN102406829A (en) | Traditional Chinese medicine composition for treating chest pain | |
| CN105213901A (en) | A kind of antigout drug compositions, its application and preparation method | |
| CN103800875A (en) | Traditional Chinese medicine for treating chronic renal failure and preparation method thereof | |
| CN104435704A (en) | Traditional Chinese medicine tablets for treating takayasu arteritis | |
| CN102631651B (en) | Method for preparing traditional Chinese medicine (TCM) for treating night sweat type colitis | |
| CN104940822A (en) | Traditional Chinese medicine preparation for treating stenocardia and preparing method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160420 |